Things are still looking rosy for JD Health, a day after the company wowed investors with an impressive trading debut for the biggest listing this year by a healthcare company in Asia.

JD Health’s shares were up 5.6% midway through the trading day on Wednesday in Hong Kong, adding to an impressive 56% gain a day earlier. Investor were drawn to the offering for the online health services unit of e-commerce giant JD.com by its big growth potential, as people do more of their medical-related purchasing and consulting online during the Covid-19 pandemic.

JD Health raised a cool $3.5 billion in the IPO, becoming the second company in JD.com’s family to make a separate listing. Shares of sister firm Dada Nexus, a grocery delivery specialist also controlled by JD.com, have more than doubled since their New York trading debut in June. Meantime, JD.com’s fintech arm has filed for a Shanghai listing, and its logistics arm is reportedly eyeing a Hong Kong IPO in the first half of next year.

JD Health recorded revenues of 8.8 billion yuan ($1.3 billion) in the first half of 2020, up from 5 billion yuan in the same period a year earlier. But its bottom line is less robust, as it moved into the loss column this year due to aggressive spending on its expansion. The company reported a 5.4 billion yuan loss in the first half of this year, reversing a 236 million yuan profit for the year-earlier period.

To read the full story, click here.

Contact reporter Yang Ge (geyang@caixin.com)